CfDNA Sequencing

Circulating free DNA (cfDNA) are degraded DNA fragments released to the blood plasma. cfDNA has been shown to be a useful biomarker for a multitude of ailments other than cancer and fetal medicine. Here is the latest research on Circulating free DNA (cfDNA) sequencing.

January 9, 2021

Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency

Clinical Lung Cancer
Jean G Bustamante AlvarezGregory A Otterson
January 14, 2021
Open Access

DISMIR: a deep learning-based cancer-detection method by integrating DNA sequence and methylation information of individual cell-free DNA reads

BioRxiv : the Preprint Server for Biology
J. LiXiaowo Wang
January 14, 2021
Open Access

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review

Annals of Translational Medicine
Oraianthi FisteFlora Zagouri
January 13, 2021

Deciphering the genetic code of DNA methylation

Briefings in Bioinformatics
Mengchi WangWei Wang
January 9, 2021

Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes

American Journal of Cancer Research
Yirizhati AiliZengliang Wang
January 12, 2021

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

Journal of the National Cancer Institute
Nadeem RiazNancy Lee
January 6, 2021
Open Access

Blood-Based Detection of Colorectal Cancer Using Cancer-Specific DNA Methylation Markers

Nam-Yun ChoGyeong Hoon Kang
January 13, 2021
Open Access

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer

Patricia Mondelo-MacíaRoberto Díaz-Peña
January 7, 2021

Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: a systematic review of their role as biomarkers

Neuropathology and Applied Neurobiology
Ana Belén Díaz MéndezMaria Giulia Rizzo
January 15, 2021

Circulating Biomarkers for Glioma: A Review

Jordan JonesAndrew Morokoff
January 14, 2021

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform

Clinical Chemistry
Ana Giménez-CapitánMiguel A Molina-Vila
January 17, 2021

Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
L SivapalanC Chelala
January 14, 2021
Open Access

Liquid biopsy in cancer using the Z-scan technique: a new approach to discover biomarkers in cancer

Future Science OA
Fernando Luiz Affonso FonsecaSarah Isabel Pinto Monteiro do Nascimento Alves
January 12, 2021
Open Access

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic Cancer

Frontiers in Genetics
Shengyue LiJing Tian
January 8, 2021
Open Access

Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report

Molecular Cytogenetics
Nuria BalaguerMiguel Milán

Sign up to follow this feed and discover related papers.

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing studies have shed light on the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). This feed follows papers using RNA sequencing technologies in Alzheimer's research.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.


Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) is a genome-wide technique used to map histone marks and protein binding (ie transcription factors) on chromatin. This can reveal insight into the regulation and dynamics of gene expression. Discover the latest research on ChIP-seq here.

Circulating Tumor DNA

Cancer cells produce circulating tumor DNA (ctDNA) which can be found in the blood stream using novel high-throughput sequencing technologies. Here is the latest research on ctDNA.

Comparative Sequencing

Inter/Intra-Species: Comparative Sequencing describes the sequencing techniques that compare between and within species genomes. Discover the latest research on comparative sequencing of inter/intra-species here.

DNA Repair & Genome Editing

Development of gene editing techniques, including CRISPR and TALENs, has relied on mechanisms that underlie DNA repair and genome stability pathways. This feed focuses on the role of DNA repair mechanisms in gene editing and genetic engineering.

© 2021 Meta ULC. All rights reserved